ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Revenue	726.44	517.24	484.15	441.76	339.08	223.81	124.9	17.33	0.06	0.12	Upgrade
Revenue Growth (YoY)	40.45%	6.83%	9.60%	30.28%	51.50%	79.19%	620.68%	28311.48%	-49.17%	-89.52%	Upgrade
Cost of Revenue	41.64	10.17	19.14	10.21	11.34	12.38	9.08	3.08	0	0	Upgrade
Gross Profit	684.8	507.07	465	431.54	327.73	211.43	115.82	14.26	0.06	0.12	Upgrade
Selling, General & Admin	406.56	369.09	396.03	388.66	325.64	265.76	255.06	186.46	88.3	32.75	Upgrade
Research & Development	351.62	361.58	239.42	319.13	240.39	187.16	149.19	99.28	73.87	60.6	Upgrade
Other Operating Expenses	0	0	0	10.34	8.25	5.95	3.98	1.33	2.5	0	Upgrade
Operating Expenses	758.18	730.67	635.44	718.13	574.28	458.87	408.23	287.07	164.67	93.35	Upgrade
Operating Income	-73.38	-223.6	-170.44	-286.59	-246.55	-247.44	-292.41	-272.82	-164.61	-93.23	Upgrade
Other Expense / Income	-22.34	-10.15	-2.92	-5.61	-12.16	-3.51	-4.13	-2.76	-0.5	-0.76	Upgrade
Pretax Income	-51.04	-213.44	-167.52	-280.97	-234.38	-243.94	-288.28	-270.05	-164.11	-92.48	Upgrade
Income Tax	10.25	2.53	0.35	0.61	0.88	1.26	1.12	1.34	0.33	0	Upgrade
Net Income	-61.29	-215.98	-167.87	-281.58	-235.26	-245.19	-289.4	-271.39	-164.44	-92.48	Upgrade
Shares Outstanding (Basic)	164	162	160	157	147	127	123	116	101	97	Upgrade
Shares Outstanding (Diluted)	164	162	160	157	147	127	123	116	101	97	Upgrade
Shares Change	1.32%	0.74%	2.01%	6.88%	16.29%	3.25%	5.82%	15.13%	3.48%	13.46%	Upgrade
EPS (Basic)	-0.37	-1.34	-1.05	-1.79	-1.60	-1.94	-2.36	-2.34	-1.63	-0.95	Upgrade
EPS (Diluted)	-0.37	-1.34	-1.05	-1.79	-1.60	-1.94	-2.36	-2.34	-1.63	-0.95	Upgrade
Free Cash Flow	16.65	-114.04	-126.78	-143.75	-152.26	-169.57	-218.57	-209.91	-123.94	-66.61	Upgrade
Free Cash Flow Per Share	0.10	-0.70	-0.79	-0.91	-1.03	-1.34	-1.78	-1.81	-1.23	-0.69	Upgrade
Gross Margin	94.27%	98.03%	96.05%	97.69%	96.65%	94.47%	92.73%	82.26%	100.00%	100.00%	Upgrade
Operating Margin	-10.10%	-43.23%	-35.20%	-64.87%	-72.71%	-110.56%	-234.11%	-1574.14%	-269855.74%	-77691.67%	Upgrade
Profit Margin	-8.44%	-41.76%	-34.67%	-63.74%	-69.38%	-109.56%	-231.71%	-1565.94%	-269578.69%	-77062.50%	Upgrade
Free Cash Flow Margin	2.29%	-22.05%	-26.19%	-32.54%	-44.90%	-75.77%	-174.99%	-1211.21%	-203173.77%	-55511.67%	Upgrade
EBITDA	-45.48	-211.42	-164.18	-278.04	-231.62	-240.93	-285.57	-268.22	-163.47	-92.27	Upgrade
EBITDA Margin	-6.26%	-40.87%	-33.91%	-62.94%	-68.31%	-107.65%	-228.64%	-1547.65%	-267977.05%	-76890.83%	Upgrade
Depreciation & Amortization	5.55	2.03	3.34	2.93	2.77	3.01	2.71	1.83	0.65	0.21	Upgrade
EBIT	-51.04	-213.44	-167.52	-280.97	-234.38	-243.94	-288.28	-270.05	-164.11	-92.48	Upgrade
EBIT Margin	-7.03%	-41.27%	-34.60%	-63.60%	-69.12%	-108.99%	-230.81%	-1558.20%	-269037.70%	-77062.50%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).